N-SAS BC06: A phase III study of adjuvant endocrine therapy with or without chemotherapy for postmenopausal breast cancer patients who responded to neoadjuvant letrozole (LET): The New Primary Endocrine-Therapy Origination Study (NEOS).
Hiroji Iwata
No relevant relationships to disclose
Shoichiro Ohtani
No relevant relationships to disclose
Tomomi Fujisawa
No relevant relationships to disclose
Naruto Taira
No relevant relationships to disclose
Norikazu Masuda
Honoraria - Chugai Pharma
Masahiro Kashiwaba
Research Funding - Chugai Pharma
Yutaka Yamamoto
No relevant relationships to disclose
Tatsuya Toyama
No relevant relationships to disclose
Takuhiro Yamaguchi
Consultant or Advisory Role - Novartis